{"name":"Corbus Pharmaceuticals","slug":"corbus-pharmaceuticals","ticker":"CRBP","exchange":"NASDAQ","domain":"corbuspharma.com","description":"","hq":"Norwood, MA","founded":0,"employees":"","ceo":"","sector":"Oncology / ADCs","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":4822272,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CRB-601 monoclonal antibody","genericName":"CRB-601 monoclonal antibody","slug":"crb-601-monoclonal-antibody","indication":"Other","status":"phase_1"},{"name":"CRB-701","genericName":"CRB-701","slug":"crb-701","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CRB-601 monoclonal antibody","genericName":"CRB-601 monoclonal antibody","slug":"crb-601-monoclonal-antibody","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CRB-701","genericName":"CRB-701","slug":"crb-701","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}